Connect with us

Business

Gilead to test inhaled form of COVID-19 drug to widen its use – msnNOW

Gilead Sciences Inc. said it plans to start human trials of an inhaled version of its anti-Covid-19 drug remdesivir, a move that could significantly expand its use if successful.

Published

on

ADVERTISEMENT

© Bloomberg
Signage is displayed outside Gilead Sciences Inc. headquarters in Foster City, California, U.S., on Thursday, March 19, 2020. Gilead Sciences stock jumped as much as 7% on Thursday, rea…

Click here to view the original article.

Continue Reading
Advertisement

You might also like ...

Article feature image
Shake Shack manager accused of poisoning shakes sues NYPD officers, union for defamation – NBC News
Article feature image
Traders look for Bitcoin price daily close at $41K to confirm bullish reversal – Cointelegraph
Article feature image
Senate confirms progressive tech critic Lina Khan to become an FTC commissioner – CNBC